Therefore, based on the molecular docking results, the present study hypothesized that baicalin, as a lead compound, may play a role in mitigating P. multocida-induced pneumonia and vascular inflammatory injury by inhibiting the dual targets COX-2 and NLRP3. This evidence concerns the gene NLRP3 and pneumonia.